Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Revenue 2018–2025
Bionexus Gene Lab Corp. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bionexus Gene Lab Corp. revenue for the quarter ending March 31, 2026 was 22842, a 98.93% decrease year-over-year.
- Bionexus Gene Lab Corp. revenue for the twelve months ending March 31, 2026 was 7.0 M, a 27.01% decrease year-over-year.
- Bionexus Gene Lab Corp. annual revenue for 2025 was 7.4 M, a 21.93% decrease from 2024.
- Bionexus Gene Lab Corp. annual revenue for 2024 was 9.5 M, a 2.66% decrease from 2023.
- Bionexus Gene Lab Corp. annual revenue for 2023 was 9.8 M, a 10.60% decrease from 2022.
- Bionexus Gene Lab Corp. annual revenue for 2022 was 10.9 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionexus Gene Lab Corp. Market Cap — FAQ
Bionexus Gene Lab Corp. (BGLC) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGLC's market cap history?
The chart and table above show Bionexus Gene Lab Corp.'s market cap by year and by quarter, including the growth rate.